Nitrostat and Portal hypertension - a phase IV clinical study of FDA data

Summary:

Portal hypertension is reported as a side effect among people who take Nitrostat (nitroglycerin), especially for people who are female, 60+ old, also take Lantus, and have Primary pulmonary hypertension.

The phase IV clinical study analyzes which people have Portal hypertension when taking Nitrostat. It is created by eHealthMe based on reports of 14,000 people who have side effects when taking Nitrostat from the FDA, and is updated regularly.

What is Nitrostat?

Nitrostat has active ingredients of nitroglycerin. It is often used in chest pain. eHealthMe is studying from 14,082 Nitrostat users. Check the latest studies of Nitrostat.

What is Portal hypertension?

Portal hypertension (increase in the blood pressure within a system of veins called the portal venous system) is found to be associated with 482 drugs and 595 conditions by eHealthMe. Check the latest studies of Portal hypertension.

On Jul, 28, 2026

14,000 people reported to have side effects when taking Nitrostat.
Among them, 11 people (0.08%) have Portal hypertension.

Could Nitrostat cause Portal hypertension?

Among these 11 people:

What is the gender of people who have Portal hypertension when taking Nitrostat? *

female: 72.73 %
male: 27.27 %

What is the age of people who have Portal hypertension when taking Nitrostat? *

What are other drugs people take besides Nitrostat? *

What are other side effects people have besides Portal hypertension? *

Abdominal Pain Upper: 8 people, 72.73%
Pleural Effusion (water on the lungs): 8 people, 72.73%
Nausea (feeling of having an urge to vomit): 7 people, 63.64%
Ascites (accumulation of fluid in the abdominal cavity): 7 people, 63.64%
Thrombocytopenia (decrease of platelets in blood): 6 people, 54.55%
Hepatic Failure (liver failure): 6 people, 54.55%
Hepatic Cirrhosis (chronic liver disease characterized by replacement of liver tissue by fibrosis, scar tissue): 6 people, 54.55%
Haemoglobin Decreased: 6 people, 54.55%
Aspartate Aminotransferase Increased: 5 people, 45.45%
Fluid Retention (an abnormal accumulation of fluid in the blood): 5 people, 45.45%

What are the existing conditions these people have? *

Primary Pulmonary Hypertension (primary high blood pressure that affects the arteries in the lungs and the right side of your heart): 5 people, 45.45%
Sciatica (a set of symptoms including pain caused by general compression or irritation of one of five spinal nerve roots of each sciatic nerve): 2 people, 18.18%
Heart Disease: 2 people, 18.18%
Hepatic Encephalopathy (spectrum of neuropsychiatric abnormalities in patients with liver failure): 1 person, 9.09%

* Approximation only. Some reports may have incomplete information.

Do you take Nitrostat and have Portal hypertension?

- Check whether Portal hypertension is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Nitrostat:

Nitrostat (14,082 reports)

Browse all side effects of Nitrostat:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Portal hypertension:

Portal hypertension (482 drugs)

Browse all the conditions that are associated with Portal hypertension:

Portal hypertension (595 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on nitroglycerin (the active ingredients of Nitrostat) and Nitrostat (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.